Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-048161

SVP, General Counsel&Secretary sold 3,888 shares at $1.33 ($5,176)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mano Michael SVP, General Counsel&Secretary 2023-09-01 Sale −3,888 $1.33 $5,176 142,234 D: show line 1 in the form
Open-market sales · 3,888 sh · avg $1.33 · $5,176
Loading xslF345X05/doc4.xml…